Cheol-Kyu Park

18PUBLICATIONS
61CO-AUTHORS
Molecular targetsPolitical economy and social changeEpidemiological modellingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 07, 2026
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.

|Apr 09, 2024
Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial.

Hyung-Joo Oh, Suk-Chul Bae, In-Jae Oh

|Jan 21, 2024
Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers.

Joon-Young Yoon, Won Ju Park, Hee Kyung Kim

|Aug 11, 2023
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study.

In-Jae Oh, Cheol-Kyu Park, Kyoung-Bok Min

|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial.

Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh

|Mar 11, 2023
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer.

Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park

Pageof 3

Frequent Collaborators

16 joint publications

In-Jae Oh

12 joint publications

Young-Chul Kim

5 joint publications

Hyung-Joo Oh

4 joint publications

Chang-Min Choi